Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment

Author:

Wong Grace Lai-Hung123ORCID,Chan Henry Lik-Yuen123ORCID,Tse Yee-Kit12,Yip Terry Cheuk-Fung12,Lam Kelvin Long-Yan12,Lui Grace Chung-Yan1,Szeto Cheuk-Chun24,Wong Vincent Wai-Sun123ORCID

Affiliation:

1. Institute of Digestive Disease; The Chinese University of Hong Kong; Hong Kong SAR China

2. Department of Medicine and Therapeutics; The Chinese University of Hong Kong; Hong Kong SAR China

3. State Key Laboratory of Digestive Disease; The Chinese University of Hong Kong; Hong Kong SAR China

4. Carol and Richard Yu Peritoneal Dialysis Research Centre; The Chinese University of Hong Kong; Hong Kong SAR China

Funder

Chinese University of Hong Kong

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Reference23 articles.

1. Current developments in nucleoside/nucleotide analogues for hepatitis B;Lo;Expert Rev Gastroenterol Hepatol,2014

2. EASL clinical practice guidelines on the management of hepatitis B virus infection;European Association for the Study of the Liver;J Hepatol,2017

3. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update;Sarin;Hepatol Int,2016

4. AASLD guidelines for treatment of chronic hepatitis B;Terrault;Hepatology,2016

5. Hepatitis B surface antigen seroclearance in a cohort of 154,740 patients with chronic hepatitis B: a 15-year follow-up study;Yip;Hepatol Int,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3